1[1]UNAIDS. Report on the global HIV/AIDS epidemic. December,2000
2[2]World HIV & AIDS Statistics. Summary of the HIV/AIDS epidem ic. December, 2000
3[3]Garfein RS, Viral infections in short - term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency and human T lymphotropic viruses. Am J Public Health, 1996, 86:655～ 661
4[4]Hagan H, McGough JP, Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol, 1999, 149:203～213
5[5]Clatts MC, HIV- 1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV- 1. J Acquir Immune Defic Syn dr, 1999,22:195 199
6[6]Littsola K, HIV 1 genetic subtype A/B recombinant strain causing an explosive outbreak in injecting drug users in Kaliningrad. AIDS, 1998, 12:1 907 1919
7[7]Nelson KE, Temporal trends of incident HIV infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med, 1995, 155:1 305 1 311
8[8]Doherty MC, Younger age of initiating injecting drug use is associated with risky behaviors and HIV infection in short term injectors. Pre sented at the XI international conference on AIDS, Vancouver, July 712, 1996
9[9]Jill Burt, Gery V Stimson. Drug injectors and HIV risk reductisn, strategies for protection. Londdon: Health education Authority, 1994
10[10]Coutinho RA. Needle exchange, pragmatism, and moralism. Am J Public Health, 2000, 90(9): 1 387～ 1 388
